Conflict of interest: none.
Original Basic Science Article
Version of Record online: 29 JUN 2010
Copyright © 2010 Wiley-Liss, Inc.
Neurourology and Urodynamics
Volume 30, Issue 1, pages 188–193, January 2011
How to Cite
Soler, R., Füllhase, C., Santos, C. and Andersson, K.-E. (2011), Development of bladder dysfunction in a rat model of dopaminergic brain lesion. Neurourol. Urodyn., 30: 188–193. doi: 10.1002/nau.20917
Lori Birder led the review process.
- Issue online: 22 DEC 2010
- Version of Record online: 29 JUN 2010
- Manuscript Accepted: 9 FEB 2010
- Manuscript Received: 20 NOV 2009
- bladder dysfunction;
- Parkinson's disease
Parkinson's disease (PD) is one of the most common neurological disorders causing lower urinary tract dysfunction. We evaluated the temporal development of bladder dysfunction in rat PD model where urodynamic changes were induced by unilateral injection of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle (MFB).
Female Sprague–Dawley rats underwent a unilateral stereotaxic injection of 6-OHDA or vehicle (sham group) into the MFB. Cystometry was performed in conscious animals at 3, 14, and 28 days after the injury. Aged-matched unlesioned rats were used as healthy controls.
Three days after lesion 6-OHDA rats showed higher threshold (TP), maximum pressures (MP), and spontaneous activity (SA) compared to healthy controls. Sham animals exhibited higher TP. After 14 days 6-OHDA rats had also higher micturition frequency, decreased bladder capacity, micturition volume and bladder compliance (Bcom) compared to sham and healthy controls. Sham animals showed lower Bcom and higher MP and SA. After 28 days, 6-OHDA rats exhibited the same changes as those in 14 days, while sham-operated animals showed parameters similar to those in healthy controls.
These findings suggest that 6-OHDA lesion of the MFB causes bladder dysfunction already after 3 days. A pattern of detrusor overactivity was more clearly defined 14 days after the injection and persisted for 28 days. Cystometry may be a useful tool to study the pathophysiology of bladder dysfunction in PD, and urodynamic parameters may possibly be used to evaluate the effects of therapeutic interventions. Neurourol. Urodyn. 30:188–193, 2011. © 2010 Wiley-Liss, Inc.